Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Project could lead to anthrax drugs

18.04.2005


A project launched at the University of Essex could lead to the development of drugs capable of reversing the effects of the anthrax bacteria.



Dr Metodi Metodiev has been awarded almost £62,500 by the National Institute of Health, USA, to investigate the deadly effects of the anthrax bacteria on human cells.

The aim is to create a screening platform by which scientists can select ’inhibitors’ capable of stopping the progress of anthrax.


Dr Metodiev said: ’Anthrax kills human cells by invading them and binding to proteins vital for specific signal transduction pathways, the signalling process by which the cell communicates with the environment and with other cells. By interrupting that signalling pathway, anthrax kills the cell and eventually the patient.’

Yeast will be used to create ’yeast cells’ with the same signalling abilities of a human cell. These will be grown in a variety of different conditions replicating the effects of anthrax, and the signalling abilities will be monitored in the presence of different test compounds.

Dr Metodiev explained the advantages of using yeast: ’It allows us to screen potential therapeutics by genetic selection. As well, ’yeast cells’ can be grown quickly which is hugely beneficial because, if anthrax were used as a bio-weapon, it is likely to have been engineered and could therefore be resistant to existing drugs. By using yeast, we may be able to subject our imitation human cells to a number of different scenarios and identify and counteract the effect of the anthrax bacteria within days.’

The project is scheduled to last for two years but Dr Metodiev hopes to extend the project by a further five years depending on the outcomes of this stage.

Kate Clayton | alfa
Further information:
http://www.essex.ac.uk/wyvern

More articles from Life Sciences:

nachricht A Map of the Cell’s Power Station
18.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

nachricht On the way to developing a new active ingredient against chronic infections
18.08.2017 | Deutsches Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>